Sizzle'S Medcos Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 27.59%
- Profit Growth -21.41%
- Ebitda -7.96%
- Net Worth 8.21%
- Total Assets -21.29%
About Sizzle'S Medcos
Sizzle's Medcos Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2017 (Seven years and ten months 8 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Sharma and Hement Kumar serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304HP2017PTC006560
- Company No.
006560
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
What products or services does Sizzle's Medcos Private Limited offer?
Sizzle'S Medcos Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Cleaning Liquids & Wipes, Surface Cleaner, Floor Cleaner, Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Sizzle'S Medcos?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Sharma  | Director | 28-Dec-2018 | Current |
| Hement Kumar | Director | 18-Apr-2017 | Current |
Financial Performance of Sizzle'S Medcos.
Sizzle'S Medcos Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 27.59% increase. The company also saw a substantial fall in profitability, with a 21.41% decrease in profit. The company's net worth moved up by a moderate rise of 8.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sizzle'S Medcos?
In 2018, Sizzle'S Medcos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sizzle'S Medcos?
Unlock and access historical data on people associated with Sizzle'S Medcos, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sizzle'S Medcos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sizzle'S Medcos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
